Redipavir Impurities are the by-products or unwanted substances that are present in the Redipavir drug formulation. These impurities can be present in trace amounts but can cause adverse effects on the drug's efficacy and safety. It is essential to identify, quantify, and control these impurities during the drug development process to ensure the drug's quality and safety. Various analytical techniques such as chromatography, mass spectrometry, and spectroscopy are used to detect and quantify Redipavir Impurities.
